Joseph Jimenez

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Joseph Jimenez
Nationality American
Alma mater Stanford University
University of California, Berkeley[1]
Occupation Former CEO of Novartis

Joseph Jimenez is the former CEO of the Swiss pharmaceutical company Novartis.[2]

Education[edit]

Jimenez earned a bachelor's degree from Stanford University in 1982, and an MBA from University of California, Berkeley's Haas School of Business in 1984.[3]

Career[edit]

Early career[edit]

Jimenez began his career at Clorox before joining ConAgra Foods.[4][non-primary source needed] Prior to joining Novartis, he was head of H. J. Heinz Company's North American business from 2002 to 2006. He was also a non-executive director of AstraZeneca from 2002 to 2007, as well as an advisor for the Blackstone Group.[1]

Novartis[edit]

Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010[5] by his predecessor and Chairman Daniel Vasella.[6]

During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis' operations. His cost-cutting moves, focused mostly on marketing and administration, came steadily, with more than a billion cut in 2010, and even more than that in 2011.[7]

Jimenez joined Board of Directors at General Motors on June 9, 2015[8]

Jimenez resigned and left Novartis in February 2018 and will be succeeded by Vasant Narasimhan.[9]


Role In Influence Peddling Scandal[edit]

Jimenez paid Michael Cohen (President Trump's lawyer) $1.2 million USD, possibly for communications or favors with President Trump.[10] Jimenez told Forbes Magazine that he brought Cohen into the company and approved the contract without knowing who Cohen was, except that he was connected to Trump and the Trump Organization.[11]


References[edit]

External links[edit]